News for Dermata Therapeutics, Inc. (DRMA)

PR NewswireSAN DIEGO, March 4, 2025 - STAR-1 topline results expected by the end of March 2025 -- Over 30 million acne patients seek treatment in the U.S.

- This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Comp

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) made a strategic move by acquiring 276,422 shares of Dermata Therapeutics Inc at a price of $1.

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechn

Dermata Therapeutics is raising $2.55M through a private placement offering to fund general corporate purposes, with insiders participating.

The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngariâ„¢ with Daxxify® to treat primary axillary hyperhidrosis -If successful, th

Dermata, Revance test new hyperhidrosis treatment

Dermata Receives Approval from FDA for the Proprietary Name Xyngari(™)

- STAR-1 topline results expected in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year -- Phase 2b for DMT310 achieved statistica

**media[462218]**

Dermata stock hits 52-week low at $1.28 amid market challenges

Israel-based Galmed Pharmaceuticals Ltd. (GLMD), a biopharmaceutical company is up over 49 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of Intel Corporation INTC rose sharply in today's pre-market trading after the company announced a strategic collaboration with AWS to help advance US-ba...

U.S. stocks traded mixed this morning, with the Dow Jones jumping over 200 points on Monday. Following the market opening Monday, the Dow traded up 0.54% to 41...

Shares of Exicure, Inc. XCUR rose sharply in today's pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq c...

Psyence Biomedical Ltd. (PBM) is up over 180 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Shares of General Dynamics Corporation GD fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter EPS results. Re...

U.S. stocks traded lower this morning, with the Dow Jones dipping around 400 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0...

Shares of Enphase Energy, Inc. ENPH rose sharply in today's pre-market trading after the company reported second-quarter financial results. Enphase Energy repo...